Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-12

Clinical Trial Update: EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill [Phase 2, Phase 3]

View source ↗

Summary

A randomized trial program (Phase 2/3) is evaluating the prevention of Acute Mountain Sickness with Suxiao Jiuxin Pill. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suxiao Jiuxin Pill

Snippet

Sponsor: Peking University First Hospital | Conditions: Acute Mountain Sickness | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING